Serum folate receptor alpha as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum folate receptor alpha as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 138, Issue 8, Pages 1994-2002
Publisher
Wiley
Online
2015-11-24
DOI
10.1002/ijc.29937
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications
- (2015) Ignace B. Vergote et al. CANCER AND METASTASIS REVIEWS
- Increased 18F-FDG Uptake of Widespread Endometriosis Mimicking Ovarian Malignancy
- (2015) Jingjie Ge et al. CLINICAL NUCLEAR MEDICINE
- IMGN853, a Folate Receptor- (FR )-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FR -Expressing Tumors
- (2015) O. Ab et al. MOLECULAR CANCER THERAPEUTICS
- Preoperative CA 125 is significant indicator of curative resection in gastric cancer patients
- (2015) Dae Hoon Kim WORLD JOURNAL OF GASTROENTEROLOGY
- Characterization of the Human Folate Receptor Alpha Via Novel Antibody-Based Probes
- (2015) Daniel J. O’Shannessy et al. Oncotarget
- Folate Receptor Alpha Expression in Lung Cancer: Diagnostic and Prognostic Significance
- (2015) Daniel J. O'Shannessy et al. Oncotarget
- Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide)
- (2014) R. T. Morris et al. ANNALS OF ONCOLOGY
- A phase I study of farletuzumab, a humanized anti-folate receptor α monoclonal antibody, in patients with solid tumors
- (2014) Yasutsuna Sasaki et al. INVESTIGATIONAL NEW DRUGS
- Conditions Associated with Circulating Tumor-Associated Folate Receptor 1 Protein in Healthy Men and Women
- (2014) Linda E. Kelemen et al. PLoS One
- Folate-receptor 1 (FOLR1) protein is elevated in the serum of ovarian cancer patients
- (2013) F. Leung et al. CLINICAL BIOCHEMISTRY
- Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer
- (2013) Deborah K. Armstrong et al. GYNECOLOGIC ONCOLOGY
- Expression of Folate Receptor-α (FRA) in Gynecologic Malignancies and its Relationship to the Tumor Type
- (2013) Daniel J. O’Shannessy et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer
- (2013) R. Wendel Naumann et al. JOURNAL OF CLINICAL ONCOLOGY
- CA125 is Superior to CA19-9 in Predicting the Resectability of Pancreatic Cancer
- (2013) Guopei Luo et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Serum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: association to disease stage and grade and comparison to CA125 and HE4
- (2013) Daniel J O’Shannessy et al. Journal of Ovarian Research
- Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome
- (2011) R. Yerushalmi et al. ANNALS OF ONCOLOGY
- MRI of Endometriotic Cysts in Association With Ovarian Carcinoma
- (2010) Yumiko Oishi Tanaka et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Functional Folate Receptor Alpha Is Elevated in the Blood of Ovarian Cancer Patients
- (2009) Eati Basal et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now